The place of real-world evidence in conducting clinical and economic analysis
Relevance. Real-world evidence (RWE) can be widely used in cost-effectiveness analysis (CEA) and budget impact analysis (BIA) conducted to justify the inclusion of new medicines in restrictive drug lists. However, researches of RWE use experience in drug assessment in the Russian Federation is curre...
Uloženo v:
| Hlavní autoři: | , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Russo |
| Vydáno: |
Publishing House OKI
2026-04-01
|
| Edice: | Реальная клиническая практика: данные и доказательства |
| Témata: | |
| On-line přístup: | https://www.myrwd.ru/jour/article/view/132 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|